UniCredit SpA (OTCMKTS:UNCFF) – Stock analysts at Jefferies Financial Group lowered their FY2020 earnings per share (EPS) estimates for UniCredit in a research note issued to investors on Wednesday, July 3rd, Zacks Investment Research reports. Jefferies Financial Group analyst B. Creelan-Sandf now anticipates that the financial services provider will post earnings per share of $2.08 for the year, down from their prior estimate of $2.14. Jefferies Financial Group also issued estimates for UniCredit’s FY2021 earnings at $2.05 EPS.

Rogers Communications (TSE:RCI) – Equities researchers at Desjardins decreased their FY2019 earnings per share (EPS) estimates for shares of Rogers Communications in a note issued to investors on Wednesday, July 24th. Desjardins analyst M. Yaghi now anticipates that the company will earn $4.54 per share for the year, down from their previous estimate of $4.56. Desjardins currently has a “Buy” rating on the stock.

Quebecor (TSE:QBR) – Analysts at National Bank Financial issued their Q2 2019 earnings per share (EPS) estimates for shares of Quebecor in a research report issued on Wednesday, July 24th. National Bank Financial analyst A. Shine anticipates that the company will post earnings per share of $0.45 for the quarter. National Bank Financial also issued estimates for Quebecor’s FY2019 earnings at $2.10 EPS and FY2020 earnings at $2.22 EPS.

TAAR Surgical (NASDAQ:STAA)’s stock price traded down 6% during trading on Thursday . The company traded as low as $30.56 and last traded at $30.70, 530,272 shares traded hands during trading. An increase of 23% from the average session volume of 430,366 shares. The stock had previously closed at $32.67.

Tivity Health Inc (NASDAQ:TVTY)’s stock price shot up 5.5% during trading on Wednesday . The stock traded as high as $16.26 and last traded at $16.25, 749,336 shares were traded during mid-day trading. A decline of 34% from the average session volume of 1,131,531 shares. The stock had previously closed at $15.40.

Pan American Silver Corp. (NASDAQ:PAAS) (TSE:PAAS)’s share price shot up 5% during trading on Wednesday . The company traded as high as $16.42 and last traded at $16.39, 4,484,287 shares were traded during trading. An increase of 89% from the average session volume of 2,371,350 shares. The stock had previously closed at $15.61.

Axovant Gene Therapies Ltd (NASDAQ:AXGT)’s stock price shot up 5.5% during trading on Wednesday . The company traded as high as $6.70 and last traded at $6.70, 153,140 shares were traded during mid-day trading. A decline of 67% from the average session volume of 457,186 shares. The stock had previously closed at $6.35.

Shares of Viveve Medical Inc (NASDAQ:VIVE) gapped down prior to trading on Wednesday . The stock had previously closed at $0.17, but opened at $0.16. Viveve Medical shares last traded at $0.17, with a volume of 694,827 shares changing hands.

Brigham Minerals Inc (NYSE:MNRL) – Equities research analysts at SunTrust Banks reduced their Q2 2019 earnings estimates for Brigham Minerals in a research note issued on Monday, July 8th, according to Zacks Investment Research. SunTrust Banks analyst W. Fitzpatrick now expects that the company will earn $0.19 per share for the quarter, down from their previous estimate of $0.20. SunTrust Banks currently has a “Buy” rating and a $28.00 price target on the stock. SunTrust Banks also issued estimates for Brigham Minerals’ Q3 2019 earnings at $0.18 EPS, Q4 2019 earnings at $0.22 EPS, FY2019 earnings at $0.68 EPS, Q1 2020 earnings at $0.23 EPS, Q2 2020 earnings at $0.23 EPS, Q3 2020 earnings at $0.24 EPS, Q4 2020 earnings at $0.25 EPS, FY2020 earnings at $0.96 EPS and FY2021 earnings at $0.98 EPS.

Crowdstrike Holdings Inc (NASDAQ:CRWD) – Equities research analysts at Oppenheimer issued their Q2 2019 earnings estimates for Crowdstrike in a research note issued on Monday, July 8th, according to Zacks Investment Research. Oppenheimer analyst S. Eyal expects that the company will earn ($0.31) per share for the quarter. Oppenheimer currently has a “Outperform” rating and a $90.00 price target on the stock. Oppenheimer also issued estimates for Crowdstrike’s Q3 2019 earnings at ($0.21) EPS and Q4 2019 earnings at ($0.19) EPS.